These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23279692)

  • 1. Precision diagnostics in transplantation: from bench to bedside.
    Mengel M; Campbell P; Gebel H; Randhawa P; Rodriguez ER; Colvin R; Conway J; Hachem R; Halloran PF; Keshavjee S; Nickerson P; Murphey C; O'Leary J; Reeve J; Tinckam K; Reed EF
    Am J Transplant; 2013 Mar; 13(3):562-8. PubMed ID: 23279692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From bench to MS bedside: challenges translating biomarker discovery to clinical practice.
    Rajasekharan S; Bar-Or A;
    J Neuroimmunol; 2012 Jul; 248(1-2):66-72. PubMed ID: 22381245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosensors for biomarkers in medical diagnostics.
    Mascini M; Tombelli S
    Biomarkers; 2008 Nov; 13(7):637-57. PubMed ID: 19061054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Issues in solid-organ transplantation in children: translational research from bench to bedside.
    Lipshultz SE; Chandar JJ; Rusconi PG; Fornoni A; Abitbol CL; Burke GW; Zilleruelo GE; Pham SM; Perez EE; Karnik R; Hunter JA; Dauphin DD; Wilkinson JD
    Clinics (Sao Paulo); 2014; 69 Suppl 1(Suppl 1):55-72. PubMed ID: 24860861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular diagnostics.
    Choe H; Deirmengian CA; Hickok NJ; Morrison TN; Tuan RS
    J Am Acad Orthop Surg; 2015 Apr; 23 Suppl(0):S26-31. PubMed ID: 25808967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovative diagnostic technologies and their significance for personalized medicine.
    Jain KK
    Mol Diagn Ther; 2010 Jun; 14(3):141-7. PubMed ID: 20560675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular diagnostics in transplantation.
    Naesens M; Sarwal MM
    Nat Rev Nephrol; 2010 Oct; 6(10):614-28. PubMed ID: 20736923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of nanobiotechnology in clinical diagnostics.
    Jain KK
    Clin Chem; 2007 Nov; 53(11):2002-9. PubMed ID: 17890442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in the clinical implementation of precision medicine companion diagnostics.
    Keeling P; Clark J; Finucane S
    Expert Rev Mol Diagn; 2020 Jun; 20(6):593-599. PubMed ID: 32336167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Better tests, better care: improved diagnostics for infectious diseases.
    Caliendo AM; Gilbert DN; Ginocchio CC; Hanson KE; May L; Quinn TC; Tenover FC; Alland D; Blaschke AJ; Bonomo RA; Carroll KC; Ferraro MJ; Hirschhorn LR; Joseph WP; Karchmer T; MacIntyre AT; Reller LB; Jackson AF;
    Clin Infect Dis; 2013 Dec; 57 Suppl 3(Suppl 3):S139-70. PubMed ID: 24200831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New diagnostic methods for pneumonia in the ICU.
    Douglas IS
    Curr Opin Infect Dis; 2016 Apr; 29(2):197-204. PubMed ID: 26859725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized nutrition diagnostics at the point-of-need.
    Lee S; Srinivasan B; Vemulapati S; Mehta S; Erickson D
    Lab Chip; 2016 Jul; 16(13):2408-17. PubMed ID: 27272753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translation of a circulating miRNA signature of melanoma into a solid tissue assay to improve diagnostic accuracy and precision.
    Laar RV; King S; McCoy R; Saad M; Fereday S; Winship I; Uzzell C; Landgren A
    Biomark Med; 2021 Sep; 15(13):1111-1122. PubMed ID: 34184547
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular predictive testing in precision oncology: The Italian experience.
    Vigliar E; Iaccarino A; Sciortino M; De Luca C; Malapelle U; Bellevicine C; Troncone G
    Cancer Cytopathol; 2020 Sep; 128(9):622-628. PubMed ID: 32885914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HER2 testing of gastro-oesophageal adenocarcinoma: a commentary and guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics Committee.
    Wong NACS; Amary F; Butler R; Byers R; Gonzalez D; Haynes HR; Ilyas M; Salto-Tellez M; Taniere P
    J Clin Pathol; 2018 May; 71(5):388-394. PubMed ID: 29439009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Companion and complementary diagnostics: an important treatment decision tool in precision medicine.
    Jørgensen JT
    Expert Rev Mol Diagn; 2020 Jun; 20(6):557-559. PubMed ID: 32342707
    [No Abstract]   [Full Text] [Related]  

  • 17. Developing potential biomarkers through bedside-to-bench translation.
    Bromage DI; Santos CX; Shah AM
    J Mol Cell Cardiol; 2019 Aug; 133():209-210. PubMed ID: 30472252
    [No Abstract]   [Full Text] [Related]  

  • 18. Protein array-based companion diagnostics in precision medicine.
    Poulsen TBG; Karamehmedovic A; Aboo C; Jørgensen MM; Yu X; Fang X; Blackburn JM; Nielsen CH; Kragstrup TW; Stensballe A
    Expert Rev Mol Diagn; 2020 Dec; 20(12):1183-1198. PubMed ID: 33315478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanochannel systems for personalized therapy and laboratory diagnostics.
    Grattoni A; Fine D; Ziemys A; Gill J; Zabre E; Goodall R; Ferrari M
    Curr Pharm Biotechnol; 2010 Jun; 11(4):343-65. PubMed ID: 20199382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A policy approach to the development of molecular diagnostic tests.
    Schulman KA; Tunis SR
    Nat Biotechnol; 2010 Nov; 28(11):1157-9. PubMed ID: 21057480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.